 | • レポートコード：GIR-105X12291 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、鼻用充血除去薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。鼻用充血除去薬の種類別市場規模（鼻孔拡張テープ、錠剤、スプレー、カプセル）、用途別市場規模（喘息、風邪、鼻アレルギー）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・鼻用充血除去薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Glaxosmithkline、Cipla、Bayer、ADAPT Pharma、Patrick Parsons、Nidda Healthcare、Procter and Gamble、Rugby Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：鼻孔拡張テープ、錠剤、スプレー、カプセル ・用途別分析2016年-2026年：喘息、風邪、鼻アレルギー ・鼻用充血除去薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・鼻用充血除去薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・鼻用充血除去薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・鼻用充血除去薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・鼻用充血除去薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nasal Decongestant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nasal Decongestant size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Nasal Decongestant market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nasal Decongestant market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nasal Strips
Tablet
Spray
Capsule
Market segment by Application can be divided into
Asthma
Cold
Nasal Allergies
The key market players for global Nasal Decongestant market are listed below:
Abbott Laboratories
Glaxosmithkline
Cipla
Bayer
ADAPT Pharma
Patrick Parsons
Nidda Healthcare
Procter and Gamble
Rugby Laboratories
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Nasal Decongestant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nasal Decongestant, with price, sales, revenue and global market share of Nasal Decongestant in 2018 and 2019.
Chapter 3, the Nasal Decongestant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nasal Decongestant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Nasal Decongestant market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Nasal Decongestant sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nasal Decongestant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nasal Decongestant Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Nasal Strips
1.2.3 Tablet
1.2.4 Spray
1.2.5 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Nasal Decongestant Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Asthma
1.3.3 Cold
1.3.4 Nasal Allergies
1.4 Global Nasal Decongestant Market Size & Forecast
1.4.1 Global Nasal Decongestant Sales in Value (2016-2026))
1.4.2 Global Nasal Decongestant Sales in Volume (2016-2026)
1.4.3 Global Nasal Decongestant Price by Type (2016-2026) & (US$/Unit)
1.5 Global Nasal Decongestant Production Capacity Analysis
1.5.1 Global Nasal Decongestant Total Production Capacity (2016-2026)
1.5.2 Global Nasal Decongestant Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nasal Decongestant Market Drivers
1.6.2 Nasal Decongestant Market Restraints
1.6.3 Nasal Decongestant Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Nasal Decongestant Product and Services
2.1.4 Abbott Laboratories Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Glaxosmithkline
2.2.1 Glaxosmithkline Details
2.2.2 Glaxosmithkline Major Business
2.2.3 Glaxosmithkline Nasal Decongestant Product and Services
2.2.4 Glaxosmithkline Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cipla
2.3.1 Cipla Details
2.3.2 Cipla Major Business
2.3.3 Cipla Nasal Decongestant Product and Services
2.3.4 Cipla Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Nasal Decongestant Product and Services
2.4.4 Bayer Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 ADAPT Pharma
2.5.1 ADAPT Pharma Details
2.5.2 ADAPT Pharma Major Business
2.5.3 ADAPT Pharma Nasal Decongestant Product and Services
2.5.4 ADAPT Pharma Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Patrick Parsons
2.6.1 Patrick Parsons Details
2.6.2 Patrick Parsons Major Business
2.6.3 Patrick Parsons Nasal Decongestant Product and Services
2.6.4 Patrick Parsons Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nidda Healthcare
2.7.1 Nidda Healthcare Details
2.7.2 Nidda Healthcare Major Business
2.7.3 Nidda Healthcare Nasal Decongestant Product and Services
2.7.4 Nidda Healthcare Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Procter and Gamble
2.8.1 Procter and Gamble Details
2.8.2 Procter and Gamble Major Business
2.8.3 Procter and Gamble Nasal Decongestant Product and Services
2.8.4 Procter and Gamble Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Rugby Laboratories
2.9.1 Rugby Laboratories Details
2.9.2 Rugby Laboratories Major Business
2.9.3 Rugby Laboratories Nasal Decongestant Product and Services
2.9.4 Rugby Laboratories Nasal Decongestant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Nasal Decongestant Sales by Manufacturer
3.1 Global Nasal Decongestant Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nasal Decongestant Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nasal Decongestant
3.4 Market Concentration Rate
3.4.1 Top 3 Nasal Decongestant Manufacturer Market Share
3.4.2 Top 6 Nasal Decongestant Manufacturer Market Share
3.5 Global Nasal Decongestant Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nasal Decongestant Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nasal Decongestant Market Size by Region
4.1.1 Global Nasal Decongestant Sales in Volume by Region (2016-2026)
4.1.2 Global Nasal Decongestant Revenue by Region (2016-2026)
4.2 North America Nasal Decongestant Revenue (2016-2026)
4.3 Europe Nasal Decongestant Revenue (2016-2026)
4.4 Asia-Pacific Nasal Decongestant Revenue (2016-2026)
4.5 South America Nasal Decongestant Revenue (2016-2026)
4.6 Middle East and Africa Nasal Decongestant Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nasal Decongestant Sales in Volume by Type (2016-2026)
5.2 Global Nasal Decongestant Revenue by Type (2016-2026)
5.3 Global Nasal Decongestant Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nasal Decongestant Sales in Volume by Application (2016-2026)
6.2 Global Nasal Decongestant Revenue by Application (2016-2026)
6.3 Global Nasal Decongestant Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nasal Decongestant Sales by Type (2016-2026)
7.2 North America Nasal Decongestant Sales by Application (2016-2026)
7.3 North America Nasal Decongestant Market Size by Country
7.3.1 North America Nasal Decongestant Sales in Volume by Country (2016-2026)
7.3.2 North America Nasal Decongestant Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nasal Decongestant Sales by Type (2016-2026)
8.2 Europe Nasal Decongestant Sales by Application (2016-2026)
8.3 Europe Nasal Decongestant Market Size by Country
8.3.1 Europe Nasal Decongestant Sales in Volume by Country (2016-2026)
8.3.2 Europe Nasal Decongestant Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nasal Decongestant Sales by Type (2016-2026)
9.2 Asia-Pacific Nasal Decongestant Sales by Application (2016-2026)
9.3 Asia-Pacific Nasal Decongestant Market Size by Region
9.3.1 Asia-Pacific Nasal Decongestant Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nasal Decongestant Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nasal Decongestant Sales by Type (2016-2026)
10.2 South America Nasal Decongestant Sales by Application (2016-2026)
10.3 South America Nasal Decongestant Market Size by Country
10.3.1 South America Nasal Decongestant Sales in Volume by Country (2016-2026)
10.3.2 South America Nasal Decongestant Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nasal Decongestant Sales by Type (2016-2026)
11.2 Middle East & Africa Nasal Decongestant Sales by Application (2016-2026)
11.3 Middle East & Africa Nasal Decongestant Market Size by Country
11.3.1 Middle East & Africa Nasal Decongestant Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nasal Decongestant Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nasal Decongestant Typical Distributors
12.3 Nasal Decongestant Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nasal Decongestant Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nasal Decongestant Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Nasal Decongestant Product and Services
Table 6. Abbott Laboratories Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 8. Glaxosmithkline Major Business
Table 9. Glaxosmithkline Nasal Decongestant Product and Services
Table 10. Glaxosmithkline Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cipla Basic Information, Manufacturing Base and Competitors
Table 12. Cipla Major Business
Table 13. Cipla Nasal Decongestant Product and Services
Table 14. Cipla Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Nasal Decongestant Product and Services
Table 18. Bayer Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. ADAPT Pharma Basic Information, Manufacturing Base and Competitors
Table 20. ADAPT Pharma Major Business
Table 21. ADAPT Pharma Nasal Decongestant Product and Services
Table 22. ADAPT Pharma Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Patrick Parsons Basic Information, Manufacturing Base and Competitors
Table 24. Patrick Parsons Major Business
Table 25. Patrick Parsons Nasal Decongestant Product and Services
Table 26. Patrick Parsons Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nidda Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Nidda Healthcare Major Business
Table 29. Nidda Healthcare Nasal Decongestant Product and Services
Table 30. Nidda Healthcare Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Procter and Gamble Basic Information, Manufacturing Base and Competitors
Table 32. Procter and Gamble Major Business
Table 33. Procter and Gamble Nasal Decongestant Product and Services
Table 34. Procter and Gamble Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Rugby Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Rugby Laboratories Major Business
Table 37. Rugby Laboratories Nasal Decongestant Product and Services
Table 38. Rugby Laboratories Nasal Decongestant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Nasal Decongestant Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Nasal Decongestant Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Nasal Decongestant, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Nasal Decongestant Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Nasal Decongestant Production Site of Key Manufacturer
Table 44. Nasal Decongestant New Entrant and Capacity Expansion Plans
Table 45. Nasal Decongestant Mergers & Acquisitions in the Past Five Years
Table 46. Global Nasal Decongestant Sales by Region (2016-2021e) & (K Units)
Table 47. Global Nasal Decongestant Sales by Region (2021-2026) & (K Units)
Table 48. Global Nasal Decongestant Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Nasal Decongestant Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Nasal Decongestant Sales by Type (2016-2021e) & (K Units)
Table 51. Global Nasal Decongestant Sales by Type (2021-2026) & (K Units)
Table 52. Global Nasal Decongestant Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Nasal Decongestant Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Nasal Decongestant Price by Type (2016-2021e) & (US$/Unit)
Table 55. Global Nasal Decongestant Price by Type (2021-2026) & (US$/Unit)
Table 56. Global Nasal Decongestant Sales by Application (2016-2021e) & (K Units)
Table 57. Global Nasal Decongestant Sales by Application (2021-2026) & (K Units)
Table 58. Global Nasal Decongestant Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Nasal Decongestant Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Nasal Decongestant Price by Application (2016-2021e) & (US$/Unit)
Table 61. Global Nasal Decongestant Price by Application (2021-2026) & (US$/Unit)
Table 62. North America Nasal Decongestant Sales by Country (2016-2021e) & (K Units)
Table 63. North America Nasal Decongestant Sales by Country (2021-2026) & (K Units)
Table 64. North America Nasal Decongestant Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Nasal Decongestant Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Nasal Decongestant Sales by Type (2016-2021e) & (K Units)
Table 67. North America Nasal Decongestant Sales by Type (2021-2026) & (K Units)
Table 68. North America Nasal Decongestant Sales by Application (2016-2021e) & (K Units)
Table 69. North America Nasal Decongestant Sales by Application (2021-2026) & (K Units)
Table 70. Europe Nasal Decongestant Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Nasal Decongestant Sales by Country (2021-2026) & (K Units)
Table 72. Europe Nasal Decongestant Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Nasal Decongestant Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Nasal Decongestant Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Nasal Decongestant Sales by Type (2021-2026) & (K Units)
Table 76. Europe Nasal Decongestant Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Nasal Decongestant Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Nasal Decongestant Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Nasal Decongestant Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Nasal Decongestant Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Nasal Decongestant Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Nasal Decongestant Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Nasal Decongestant Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Nasal Decongestant Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Nasal Decongestant Sales by Application (2021-2026) & (K Units)
Table 86. South America Nasal Decongestant Sales by Country (2016-2021e) & (K Units)
Table 87. South America Nasal Decongestant Sales by Country (2021-2026) & (K Units)
Table 88. South America Nasal Decongestant Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Nasal Decongestant Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Nasal Decongestant Sales by Type (2016-2021e) & (K Units)
Table 91. South America Nasal Decongestant Sales by Type (2021-2026) & (K Units)
Table 92. South America Nasal Decongestant Sales by Application (2016-2021e) & (K Units)
Table 93. South America Nasal Decongestant Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Nasal Decongestant Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Nasal Decongestant Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Nasal Decongestant Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Nasal Decongestant Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Nasal Decongestant Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Nasal Decongestant Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Nasal Decongestant Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Nasal Decongestant Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Nasal Decongestant Typical Distributors
Table 105. Nasal Decongestant Typical Customers
List of Figures
Figure 1. Nasal Decongestant Picture
Figure 2. Global Nasal Decongestant Sales Market Share by Type in 2020
Figure 3. Nasal Strips
Figure 4. Tablet
Figure 5. Spray
Figure 6. Capsule
Figure 7. Global Nasal Decongestant Sales Market Share by Application in 2020
Figure 8. Asthma
Figure 9. Cold
Figure 10. Nasal Allergies
Figure 11. Global Nasal Decongestant Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Nasal Decongestant Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Nasal Decongestant Sales (2016-2026) & (K Units)
Figure 14. Global Nasal Decongestant Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Nasal Decongestant Production Capacity (2016-2026) & (K Units)
Figure 16. Global Nasal Decongestant Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Nasal Decongestant Market Drivers
Figure 18. Nasal Decongestant Market Restraints
Figure 19. Nasal Decongestant Market Trends
Figure 20. Global Nasal Decongestant Sales Market Share by Manufacturer in 2020
Figure 21. Global Nasal Decongestant Revenue Market Share by Manufacturer in 2020
Figure 22. Nasal Decongestant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Nasal Decongestant Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Nasal Decongestant Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Nasal Decongestant Sales Market Share by Region (2016-2026)
Figure 26. Global Nasal Decongestant Revenue Market Share by Region (2016-2026)
Figure 27. North America Nasal Decongestant Revenue (2016-2026) & (USD Million)
Figure 28. Europe Nasal Decongestant Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Nasal Decongestant Revenue (2016-2026) & (USD Million)
Figure 30. South America Nasal Decongestant Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Nasal Decongestant Revenue (2016-2026) & (USD Million)
Figure 32. Global Nasal Decongestant Sales Market Share by Type (2016-2026)
Figure 33. Global Nasal Decongestant Revenue Market Share by Type (2016-2026)
Figure 34. Global Nasal Decongestant Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Nasal Decongestant Sales Market Share by Application (2016-2026)
Figure 36. Global Nasal Decongestant Revenue Market Share by Application (2016-2026)
Figure 37. Global Nasal Decongestant Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Nasal Decongestant Sales Market Share by Type (2016-2026)
Figure 39. North America Nasal Decongestant Sales Market Share by Application (2016-2026)
Figure 40. North America Nasal Decongestant Sales Market Share by Country (2016-2026)
Figure 41. North America Nasal Decongestant Revenue Market Share by Country (2016-2026)
Figure 42. United States Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Nasal Decongestant Sales Market Share by Type (2016-2026)
Figure 46. Europe Nasal Decongestant Sales Market Share by Application (2016-2026)
Figure 47. Europe Nasal Decongestant Sales Market Share by Country (2016-2026)
Figure 48. Europe Nasal Decongestant Revenue Market Share by Country (2016-2026)
Figure 49. Germany Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Nasal Decongestant Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Nasal Decongestant Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Nasal Decongestant Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Nasal Decongestant Revenue Market Share by Region (2016-2026)
Figure 58. China Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Nasal Decongestant Sales Market Share by Type (2016-2026)
Figure 65. South America Nasal Decongestant Sales Market Share by Application (2016-2026)
Figure 66. South America Nasal Decongestant Sales Market Share by Country (2016-2026)
Figure 67. South America Nasal Decongestant Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Nasal Decongestant Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Nasal Decongestant Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Nasal Decongestant Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Nasal Decongestant Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Nasal Decongestant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の充血除去薬市場 2021：企業別、地域別、種類・用途別 The Decongestant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…- 世界の点鼻スプレーボトル市場 2021：企業別、地域別、種類・用途別 The Nasal Spray Bottles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の点鼻スプレー式インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Nasal Spray Flu Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- コルチコステロイドスプレー式点鼻薬の世界市場2018-2025 In 2018, the global Corticosteroid Nasal Spray market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Corticosteroid Nasal Spra…
- 鼻用アゼラスチン-フルチカゾンの世界市場2018-2025 Azelastine and fluticasone combination nasal spray is used to treat an itchy or runny nose, sneezing, or other symptoms caused by seasonal hay fever (allergic rhinitis).In 2018, the global Azelastine-Fluticasone Nasal market size was xx million US$ and is forecast to xx million US in 2025, growing a…